Exscientia’s Post

Great to see Dave H., our CEO (interim) and CSO, speak to BiotechTV discussing the tightly knit integration of our automated experimentation and generative AI capabilities, and how that drives our oncology focused pipeline forward. Watch this informative interview for insights into upcoming developments, and our learnings as a public technology-driven drug design company: https://lnkd.in/gZXrb8Ub #AI #drugdevelopment #oncology

Exscientia's CEO shares a pipeline overview and learnings from being one of the first AI companies out front and to go public

Exscientia's CEO shares a pipeline overview and learnings from being one of the first AI companies out front and to go public

biotechtv.com

To view or add a comment, sign in

Explore topics